Internal Medicine, Pulmonary Disease · Spokane, WA
NPI
1689895211
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
4
Medicare group memberships
Hospitals
6
Hospital affiliations
212 E Central Ave, Suite 315
Spokane, WA, 99208
Phone (509) 465-3919
Groups this clinician bills Medicare through
Medicare paid, 2024
$142K
2,418 services
Medicare patients, 2024
559
Average age 75
Drug cost, 2024
$4.8M
3,009 prescriptions
Company payments, 2025
$34K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jiten D Patel was code 94729 (pulmonary function testing), 342 times for 325 patients. In total Jiten D Patel billed 2,418 services in 56 codes, and Medicare paid $142K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94729 Pulmonary Function Testing | Office | 342 | 325 | $41.96 | $14K |
| 94726 Pulmonary Function Testing | Office | 339 | 322 | $42.23 | $14K |
| 94010 Pulmonary Function Testing | Office | 245 | 235 | $21.02 | $5,150 |
| 99443 Telephone Services | Office | 129 | 119 | $98.94 | $13K |
| 31645 Bronchoscopy | Facility | 128 | 121 | $23.82 | $3,049 |
| 99204 Office E&M - New | Office | 120 | 120 | $122.08 | $15K |
| 94060 Pulmonary Function Testing | Office | 105 | 101 | $30.66 | $3,219 |
| 31624 Bronchoscopy | Facility | 99 | 97 | $1.81 | $179 |
| 99214 Office E&M - Established | Office | 98 | 95 | $98.14 | $9,618 |
| 31654 Bronchoscopy | Facility | 89 | 87 | $49.99 | $4,449 |
| 31628 Bronchoscopy | Facility | 65 | 64 | $37.85 | $2,460 |
| 31627 Bronchoscopy | Facility | 57 | 55 | $72.17 | $4,114 |
| 31629 Bronchoscopy | Facility | 56 | 54 | $137.05 | $7,675 |
| 94618 Pulmonary Function Testing | Office | 53 | 50 | $27.04 | $1,433 |
| 31626 Bronchoscopy | Facility | 47 | 46 | $74.00 | $3,478 |
By year: 2022 $144K for 2,393 services; 2023 $164K for 2,700 services; 2024 $142K for 2,418 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jiten D Patel prescribed most often to Medicare patients was Stiolto Respimat (Tiotropium Br/Olodaterol Hcl), with 498 prescriptions and refills. In total Jiten D Patel wrote 3,009 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 498 | 635 | 131 | $278K |
| Montelukast Sodium Generic | 265 | 515 | 65 | $2,915 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 248 | 334 | 60 | $210K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 241 | 291 | 96 | $7,520 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 178 | 234 | 40 | $103K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 153 | 161 | 26 | $97K |
| Roflumilast Generic | 127 | 153 | 26 | $7,003 |
| Azithromycin Generic | 98 | 117 | 60 | $727 |
| Arnuity Ellipta Fluticasone Furoate | 80 | 124 | 16 | $25K |
| Tyvaso Dpi Treprostinil | 79 | 79 | 13 | $1.8M |
| Prednisone Generic | 78 | 84 | 65 | $295 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 72 | 91 | 18 | $405 |
| Spiriva Respimat Tiotropium Bromide | 61 | 75 | 14 | $35K |
| Opsumit Macitentan | 59 | 59 | Under 11 | $744K |
| Doxycycline Hyclate Generic | 58 | 58 | 56 | $642 |
Brand drugs: 1,800 claims; generic drugs: 1,209 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jiten D Patel $34K ($34K in general payments such as food, travel and fees) from 20 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 34 | $23K |
| United Therapeutics Corporation UTHR | 15 | $8,220 |
| Steris Corporation STE | 5 | $1,438 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $314 |
| GlaxoSmithKline, LLC. GSK | 24 | $242 |
| Merck Sharp & Dohme LLC MRK | 4 | $119 |
| Electromed, Inc. ELMD | 5 | $92.97 |
| Verona Pharma, Inc. VRNA | 4 | $86.69 |
| Genzyme Corporation SNY | 4 | $77.26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73.34 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.